drugset / Trial / NCT01370460

Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty

NCT01370460

Phase 2 Completed 101 enrolled Henry Ford Health System
RandomizedParallel-groupTriple-blindTreatment

Summary

This study aims to assess postoperative blood loss and transfusion rates in total knee replacement after one-time administration of topical tranexamic acid.

Timeline

Start
2011-06
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 2 g Topical